HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles.

Abstract
Pertussis has resurged during the last two decades in different countries. In particular in the 2010-2013 period large outbreaks were detected in US, Australia, UK and The Netherlands with significant mortality in infants. The epidemiological situation of pertussis points out the need to develop new vaccines and in this regard we previously developed a new vaccine based on outer membrane vesicles (OMVs) which have been shown to be safe and to induce protection in mice. Here we have further investigated the properties of OMVs vaccines; in particular we studied the contribution of pertussis toxin (PTx) and pertactin (Prn) in OMVs-mediated protection against pertussis. PTx-deficient OMVs and Prn-deficient OMVs were obtained from defective Bordetella pertussis mutants. The absence of PTx or Prn did compromise the protective capacity of the OMVs formulated as Tdap vaccine. Whereas the protective efficacy of the PTx-deficient OMVs in mice was comparable to Prn-deficient OMVs, the protective capacity of both of them was significantly impaired when it was compared with the wild type OMVs. Interestingly, using OMVs obtained from a B. pertussis strain which does not express any of the virulence factors but expresses the avirulent phenotype; we observed that the protective ability of such OMVs was lower than that of OMVs obtained from virulent B. pertussis phase. However, it was surprising that although the protective capacity of avirulent OMVs was lower, they were still protective in the used mice model. These results allow us to hypothesize that OMVs from avirulent phase shares protective components with all OMVs assayed. Using an immune proteomic strategy we identified some common components that could play an important role in protection against pertussis.
AuthorsMaximiliano Ormazábal, Erika Bartel, María Emilia Gaillard, Daniela Bottero, Agustina Errea, M Eugenia Zurita, Griselda Moreno, Martin Rumbo, Celina Castuma, Dario Flores, María Julia Martín, Daniela Hozbor
JournalVaccine (Vaccine) Vol. 32 Issue 46 Pg. 6084-90 (Oct 21 2014) ISSN: 1873-2518 [Electronic] Netherlands
PMID25240753 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • Antigens, Bacterial
  • Bacterial Outer Membrane Proteins
  • Pertussis Vaccine
  • Virulence Factors, Bordetella
  • pertactin
  • Pertussis Toxin
Topics
  • Animals
  • Antigens, Bacterial (immunology)
  • Bacterial Outer Membrane Proteins (immunology)
  • Female
  • Mice, Inbred BALB C
  • Pertussis Toxin (immunology)
  • Pertussis Vaccine (immunology)
  • Virulence Factors, Bordetella (immunology)
  • Whooping Cough (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: